Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
08/2010
08/19/2010WO2010092963A1 Drug transporter, and adjuvant and vaccine each utilizing same
08/19/2010WO2010092925A1 Solid dispersion, pharmaceutical composition comprising the solid dispersion, and processes for producing the solid dispersion and the pharmaceutical composition
08/19/2010WO2010092828A1 Disintegrating particle composition and rapidly disintegrating compression-molded material comprising same
08/19/2010WO2010092468A1 Composition comprising alginates and d-limonene to treat gerd and dyspepsia
08/19/2010WO2010092224A1 Biopolymer, implant comprising it and uses thereof
08/19/2010WO2010091650A1 Polymeric conjugates of paclitaxel and docetaxel with ph-controlled releasing of the cancerostatic agent
08/19/2010WO2010077671A3 Stable perfluorocarbon emulsion for use as an artificial oxygen carrier
08/19/2010WO2010072421A3 Hydrogel composition for the treatment of dermatological disorders
08/19/2010WO2010066034A8 Narcotic drug formulations with decreased abuse potential
08/19/2010WO2010062059A3 Hydrogel type cell delivery vehicle for wound healing, and preparation method thereof
08/19/2010WO2010059565A3 Allografts combined with tissue derived stem cells for bone healing
08/19/2010WO2010058924A3 Fast dissolving oral tablets and method for production thereof
08/19/2010WO2010053306A3 Pharmaceutical composition for the controlled release of methylphenidate
08/19/2010WO2010052243A3 Neurotensin-derived branched peptides and uses thereof
08/19/2010WO2010045281A3 Stable aqueous formulations of water insoluble or poorly soluble drugs
08/19/2010WO2010045209A9 Methods of treating pulmonary disorders with liposomal amikacin formulations
08/19/2010WO2010039861A3 Dendrimer conjugates
08/19/2010WO2010039163A3 Chemical and biochemical adducts as biomarkers for organophosphate exposure
08/19/2010WO2010032248A3 Multifunctional albumin conjugates
08/19/2010WO2010022320A3 Polymeric benzyl carbonate-derivatives
08/19/2010WO2010005732A8 Composition and method of preparation of release systems for constant (zero-order) release of active agents
08/19/2010US20100210792 Drug delivery
08/19/2010US20100210736 Method for stabilizing calcium phosphates fine particles, method for manufacturing calcium phosphates fine particles by using the method, and use thereof
08/19/2010US20100210729 Methods of inducing terminal differentiation
08/19/2010US20100210715 Biodegradable cationic polymers
08/19/2010US20100210676 Chemically Modified Small Molecules
08/19/2010US20100210615 Compositions and methods for enhancing corticosteroid delivery
08/19/2010US20100210614 Compositions and methods for enhancing corticosteroid delivery
08/19/2010US20100210609 Free of medium chain glycerides; topical delivery to skin; vehicle comprising at least two penetration enhancers such as propylene glycol, diisopropyl adipate, dimethyl isosorbide, 1,2,6-hexanetriol, and benzyl alcohol, as well as solvents and emulsifiers
08/19/2010US20100210607 Hydrogen sulfide derivatives of non-steroidal anti-inflammatory drugs
08/19/2010US20100210569 Mitochondria-targeting antioxidant therapeutics
08/19/2010US20100210518 Peg-lipid conjugates for increasing the solubility of drug compounds
08/19/2010US20100210515 Methods for preparing purified polypeptide compositions
08/19/2010US20100210504 Enhanced transport using membrane disruptive agents
08/19/2010US20100209581 Food intermediate having sequestered phytosteryl esters in a polysaccharide matrix
08/19/2010US20100209529 Pharmacologic-functioning water and usage of the same
08/19/2010US20100209526 Product comprising a combination of milk serum apoproteins and free fatty acids
08/19/2010US20100209524 Encapsulated agglomeration of microcapsules and method for the preparation thereof
08/19/2010US20100209514 Method of treating pain by administering 24 hour oral oploid formulations exhibiting rapid rate of initial rise of plasma drug level
08/19/2010US20100209509 Bifunctional-modified hydrogels
08/19/2010US20100209503 Bitter Taste Masking Dosage Form
08/19/2010US20100209499 Solid Oral Dosage Form Containing an Enhancer
08/19/2010US20100209494 Liposomes and Uses Thereof
08/19/2010US20100209449 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
08/19/2010US20100209448 Synthetic anti-candida albicans oligosaccharide based vaccines
08/19/2010US20100209438 OVR110 Antibody Compositions and Methods of Use
08/19/2010US20100209405 Sericin extracted silkworm fibroin fibers
08/19/2010US20100209392 Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith
08/19/2010US20100209389 Multi-Compartmented Container
08/19/2010US20100209370 Skin treatment composition
08/19/2010US20100209361 Highly cationic copolymers based on quaternized nitrogen-containing monomers
08/19/2010US20100209353 Tumor targeting protein conjugate and a method for preparing the same
08/19/2010US20100209351 Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
08/19/2010US20100209347 Cyclodextrin compound modified with folic acid, process for production thereof, drug delivery agent for targeting drug delivery system, pharmaceutical composition, and imaging agent
08/19/2010DE102009008186A1 Feste orale pharmazeutische Zusammensetzung umfassend einen hydrophoben Wirkstoff A solid oral pharmaceutical composition comprising a hydrophobic drug
08/19/2010DE102009008185A1 Zusammensetzung umfassend einen hydrophoben Wirkstoff sowie ein Phospholipid A composition comprising a hydrophobic drug and a phospholipid
08/19/2010DE102004058893B4 Modifizierte Biopolymere, mineralisierte modifizierte Biopolymere, Verfahren zu deren Herstellung und deren Verwendungen Modified biopolymers, modified biopolymers mineralized, to processes for their preparation and their uses
08/19/2010CA2752070A1 Foamable benzoyl peroxide compositions for topical administration
08/19/2010CA2752069A1 Composition comprising biodegradable carrier for controlled drug delivery
08/19/2010CA2751703A1 Hard capsule
08/19/2010CA2751449A1 Foamable microemulsion compositions for topical administration
08/19/2010CA2749501A1 Immunoconjugates with an intracellularly-cleavable linkage
08/19/2010CA2726230A1 The stabilisation of proteins
08/18/2010EP2218718A1 Amorphous form of heterocyclic compound, solid dispersion and medicinal preparation each comprising the same, and process for production of the same
08/18/2010EP2218459A1 Sustained release composition containing sdf-1
08/18/2010EP2218446A1 Method for producing microcapsule using solid fat
08/18/2010EP2218443A1 Orally disintegrating tablet
08/18/2010EP2218424A1 Intraocular drug delivery systems
08/18/2010EP2217284A2 Lipid-modified double-stranded rna having potent rna interference effect
08/18/2010EP2217283A2 Biocompatible biodegradable fumagillin analog conjugates
08/18/2010EP2217281A2 Photonic shell-core cross linked and functionalized nanostructures for biological applications
08/18/2010EP2217280A1 Diagnostic and therapeutic methods and compositions for cardiovascular disease
08/18/2010EP2217279A2 Preparations, methods and kits useful for treatment of cough
08/18/2010EP2217278A1 Dry powder formulations comprising ascorbic acid derivates
08/18/2010EP2217277A2 Stabilization of hydrophobic protein therapeutic agents
08/18/2010EP2217219A2 A sublingual effervescent tablet of progesterone associated with cyclodextrin
08/18/2010EP2217216A1 Formulations for enhanced bioavailability of orally administered polar agents
08/18/2010EP2217209A1 Novel thermosensitive liposomes containing therapeutic agents
08/18/2010EP2217208A2 Nucleic acid complex and nucleic acid delivery composition
08/18/2010EP2217204A2 Compositions for the topical protection of the ocular tissues from the damaging effects of ultraviolet radiations
08/18/2010EP2217063A1 Thiolated paclitaxels for reaction with gold nanoparticles as drug delivery agents
08/18/2010EP2004696B1 Antibody molecules specific for fibroblast activation protein and immunoconjugates containing them
08/18/2010EP1626983B1 Novel poly (ethylene glycol) modified erythropoietin agonists and uses thereof
08/18/2010EP1461360B1 Conjugates comprising an antibody specific for the ed-b domain of fibronectin and their use for the detection and treatment of tumours
08/18/2010EP1443899B1 Bowel cleansing agent
08/18/2010EP1426380B1 Association compound of trehalose or maltitol with metal ion compound
08/18/2010EP1420025B1 Powder comprising water-containing beta-maltose crystals and production process and use thereof
08/18/2010EP1417222B1 Isolated polypeptides based on the neutralizing epitope of the p17 protein of hiv useful as vaccines, and neutralizing anti-p17 antibodies which specifically recognize said neutralizing epitope
08/18/2010EP1411910B1 (+)-cycloolivil as antioxidant obtained from stereospermum personatum
08/18/2010EP1392321B1 Method of treating inflammatory disorders of the gastrointestinal tract using topical active corticosteroids
08/18/2010EP1140009B2 Absorbent article composition and use thereof for sequestering skin irritants.
08/18/2010CN1835752B Multivitamin syrup for children or young adults
08/18/2010CN1729018B G-CSF conjugates
08/18/2010CN1704121B Anti-angiogenic compositions and methods of use
08/18/2010CN101809039A Cyclodextrin compound modified with folic acid, process for production thereof, drug delivery agent for targeting drug delivery system, pharmaceutical composition, and imaging agent
08/18/2010CN101809029A Peptide capable of extending half-life of peptide of interest in plasma
08/18/2010CN101808668A Active targeting type polymeric micelle carrying drug enclosed therein and medicinal composition
08/18/2010CN101808667A Medicinal preparation for oral administration
08/18/2010CN101808651A polymer conjugate of steroid
08/18/2010CN101808639A Antifungal pharmaceutical composition
1 ... 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 ... 1712